Autor: Antonio Berlen

New partnership: joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

Veröffentlicht am von Antonio Berlen

(Karlsruhe-GER, 16 June 2020)

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

“joimax® is looking forward to working with a partner strong as JMC, says joimax® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan”. Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

CMS Includes Endoscopic Spine in Fee Schedule Proposed Rule for CY 2017

Veröffentlicht am von Antonio Berlen

Baltimore, MD – July 14, 2016– The Centers for Medicare & Medicaid Services (CMS) recently released the proposed rules for the 2017 Medicare Physician Fee Schedule (MPFS) and the 2017 Hospital Outpatient Prospective Payment System (HOPPS). Both proposed rules provide information on physician and hospital payment for the newly created CPT code 630X1 for endoscopic decompression of the lumbar spine.

“This is a great step towards the acceptance of endoscopic minimally invasive spine surgery techniques and their benefits to both the surgeon and their patients in the U.S.,” said Wolfgang Ries, Founder and CEO of joimax®. This announcement is in alignment with the reimbursement decision of NICE, UK, in April of 2016, to fully reimburse endoscopic procedures.

A key reason for the recent momentum for endoscopic, minimally invasive spinal surgery is the significant, favorable base of literature, which validates evidence of the efficacy of endoscopic minimally invasive spine surgery. A special edition, “Neurosurgical Focus”, published by the Journal of Neurosurgery (JNS) in February 2016, contains a range of studies on endoscopic spine surgery.

The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® To Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery

Veröffentlicht am von Antonio Berlen

San Diego, Oct. 20, 2011 – The Society for Minimally Invasive Spine Surgery (SMISS), San Diego, CA and joimax®, Karlsruhe, Germany announced today the signing of an agreement to support the SMISS Registry as a founding sponsor for creation and launch of the SMISS Spine Registry for Minimally Invasive Endoscopic Spine Surgery. The SMISS Spine Registry was designed to collect valuable data concerning decreased hospitalization, recovery times, and complication rates of endoscopic spine procedures, as well as increased quality of life measures, subject satisfaction, and cost effectiveness. In today’s rapidly changing healthcare climate, it is imperative to ensure the ongoing availability of this data regarding efficiencies of care and quality of outcomes.

SMISS has assembled an outstanding research team with extensive experience within the spine field. The Principal Investigator for the Registry, Choll Kim, M. D., Ph.D, Executive Director and Board of Directors Member of SMISS states, “We are excited to partner with joimax® in the launch of the SMISS Registry, a project that will produce the relevant data collection and management necessary for the continued growth of minimally invasive endoscopic spine surgery. The Society will lead the way in the collection of minimally invasive spine surgery outcomes and cost data. SMISS is positioned to become the model for successful spine research.”

“joimax® and SMISS are ideal partners to begin this important project in spinal endoscopy. The data collected will assist both parties in furthering the development of minimally invasive endoscopic spinal surgery, which is a great benefit to patients around the world,” said Wolfgang Ries, CEO and Founder of joimax. “We are pleased to provide funding for this important project.”

This three year, multi-centered project will commence patient enrollment in late 2011. The Registry is expected to enroll a minimum of 250 patients during the first phase of the project.

Rapid company growth prompts joimax® Inc. to move its US headquarters to a new, larger state-of-the-art facility

Veröffentlicht am von Antonio Berlen

Irvine, CA – November 5, 2018 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the move of its US headquarters to a new 26,000-square-foot facility in Irvine, California, beginning November 5, 2018.
“With the move to the new building, the steadily growing need for endoscopic procedures among patients and physician communities can now be efficiently met,” states Wolfgang Ries, Founder and CEO of the joimax® Group. “Growth requires space — the continued demand in the US market creates a major opportunity which joimax® Inc. is addressing with the expansion of its US organization.”
The new office is located at 140 Technology Drive, Suite 150 in the city of Irvine and includes a brand new training and education center. The center offers a demonstration and wet lab training room displaying all joimax® systems and products, as well as a big audience room for didactics presentations. The first workshop will be held at the center on Nov 30th – Dec 1st, 2018.
In addition, the new facility will handle all corporate and business functions. Over the next year, joimax® Inc. will add more clinical support, marketing, and sales personnel in order to face the fast growing demand for endoscopic spine procedures.

Veröffentlicht in Allgemein

joimax® at the AANS in Washington, D.C.

Veröffentlicht am von Antonio Berlen

From May 2-6, the 83rd American Association of Neurological Surgeons (AANS) Annual Scientific Meeting welcomed more than 3,000 medical attendees to Washington, D.C., to celebrate and reflect on both the history and future of neurosurgery.

The team from joimax® Inc. (Irvine, CA, US) participated in this important event as a corporate partner and showcased its products for minimally invasive spine surgery (MISS). Traffic to the booth was high and the team was very satisfied with the outcome of the meeting. One topic that came up during many discussions with the visiting attendees was the screw-rod system Percusys® for spinal stabilization. The product received 510k clearance in March.

joimax® founder and CEO Wolfgang Ries from Karlsruhe, Germany, was invited as the keynote speaker for the Practical Clinic session “Invention and Innovation in Neuro- and Spine Surgery”. His one hour lecture on the first day of the AANS meeting presented a compelling picture on how joimax® evolved since 2001 when the company was founded. Key products and technologies were presented as well which led to engaged discussions after the lecture. Teodoro Forcht-Dagi, Co-Director of the session, commented: „joimax® is a remarkable example of an innovative start-up company that evolved to a successful mid-size local company. Its efforts to work with surgeons and refine MISS technology for the safety and benefit of patients are admirable. A large part of its success is attributable to the combination of technical quality and meticulous training. The company’s contribution to the development of MISS is huge.”

„The AANS Annual Meeting is extremely worthwhile to be at.” emphasized Wolfgang Ries. “For joimax® it was a great opportunity to interact with neurosurgeons and to discuss our well-established MISS techniques and products – made in Germany.”

joimax® holds the first international TESSYS® User Meeting in Veenhuizen, The Netherlands, and announces the launch of various new products for endoscopic spinal surgery

Veröffentlicht am von Antonio Berlen

Karlsruhe, 12. May 2010. On 14 and 15 May 2010 joimax® GmbH holds the first international user meeting of endoscopic spinal surgery in Veenhuizen/Netherlands. Besides the ten reference surgeons about 30 participants and customers from Germany, Europe, the United States and other countries are expected to join the meeting. The scientific program comprises atwo-days conference which be opened with a keynote lecture of Prof. Dr. Gerbrand J. Groen of the university of Utrecht. CEO and founder of the company Wolfgang Ries will give an outline of the product offensive in the coming months in the field of access systems, ablation and drilling systems and the latest joimax® HD technologies.

One of the highlights of this event will be the opening ceremony of Rugkliniek Iprenburg in Veenhuizen. The head of this private clinic Dr. Menno Iprenburg, a long-time member of the joimax® Faculty, having completed more than 900 TESSYS® surgeries, states: „It was the right decision to give up my position as chief surgeon in Assen and to risk once again total self-employment with the joimax® TESSYS® method“, and, „this is also proven by the significantly increasing number of patients and the possibility of operating more indications with the joimax® endoscopic methods “.

Veröffentlicht in 2010

joimax® Recieves FDA Clearance to Market EndoLIF® Delta-Cage and DoubleWedge-Cage in the USA

Veröffentlicht am von Antonio Berlen

Karlsruhe (GER) — German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce that it has received FDA clearance to market the EndoLIF® Delta-Cage and EndoLIF® DoubleWedge-Cage in the United States. Delta-Cages and DoubleWedge-Cages are intended for intervertebral body fusion procedures for various diseases of the lumbar spine, such as degenerative disc disease.

Now in its 20th anniversary year, joimax® sets another milestone by providing a family of 3D printed titanium cages. The complete EndoLIF® product portfolio consists of the Delta-Cage, the DoubleWedge-Cage, and the O/On-Cage. All three models are designed with special features:

  • 3D printed titanium for excellent bone ingrowth, fillable with bone or bone substitute material, pre- or post-insertion
  • Anatomical shape and lordotic correction options for OLIF, TLIF, and PLIF procedures
  • “Over-the-wire” implantation for optimal targeted positioning in the intervertebral disc space
  • Endoscopic control of all surgical steps due to the EndoLIF® platform technology

“It is impressive how well these cages ensure primary stability, especially the DoubleWedge-Cage,” says Dr. Ralf Wagner, head surgeon and founder of the Ligamenta Spine Centre in Frankfurt.

Image of Intracs system ; Fda approved ; minimally invasive spine surgery ; Joimax ; endoscopy

Many other experts including, Dr. Florian Zentz, head surgeon of the spine center in Tutzing (Munich), Dr. Ricardo Casal Grau, orthospine surgeon from Madrid, and Dr. J. N. Alastair Gibson, spinal surgeon from Edinburgh, supported the development of the joimax® cages.

“With FDA clearance of two of our cages, our EndoLIF® platform gets more complete; the next major step in endoscopic spinal surgery is endoscopically-assisted fusion,” says joimax® Founder and CEO Wolfgang Ries. “More and more centers are proving the efficacy of these procedures in studies, demonstrating once again the major benefits of endoscopy in fusion. So far, our cages are well established in Europe and in selected centers in Asia, and now we are entering the USA, the biggest market for spinal fusion”.

joimax® celebrates its 10th anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

Veröffentlicht am von Antonio Berlen

Karlsruhe, Germany – April 11th, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax® organized the presentation of its latest systems like the TESSYS® ISeeU and iLESSYS® Delta in product trainings as well as newest tools for endoscopic treatment in an exhibition hall. The program was supported by joimax® Faculty Members from Europe, USA and other countries. In the course of the meeting a Chinese Faculty Team with 13 members was inaugurated by Wolfgang Ries, Founder and CEO of joimax® and Qin-Guang You, President of joimax® China. ”Due to the growing education and training needs in the Asian region the time has come to form a local team for this important market”, explains Wolfgang Ries. “It is a great honor to lead this team and to support the further growth of joimax®”, says the head of the Faculty Team, Prof. Yue Zhou from the Third Military Medical University in Chongqing. He was awarded with the joimax® Handshake Award in Gold for his exceptional commitment and the members of the group received the joimax® Handshake Award in Silver.

After very satisfying growing sales figures in 2016 (31 % growth vs. 2015), joimax® is proud to announce a jump in sales in the first quarter 2017. Consolidated figures show an increase of 60 % compared to the same period of last year. “This is a very encouraging development, showing the continuing expansion and growth of the group”, states Wolfgang Ries, Founder and CEO of joimax®.

joimax® at the autumn congresses: EuroSpine Liverpool and NASS New Orleans

Veröffentlicht am von Antonio Berlen

Karlsruhe/Irvine, October 29th 2013

Dear partners and friends,

it was our great pleasure to launch and present our latest product developments at the major spine congresses: EuroSpine as the most important spine congress on the European level and NASS as the most renowned and biggest one in the US. Please find here some impressions of both of the venues in Liverpool and New Orleans.

At both congresses our novel EndoLIF® and Percusys® (both not yet FDA cleared) technologies for endoscopic lumbar interbody fusion and percutaneous fixation were in the limelight, besides the earlier in the year launched CESSYS® and Multiuse RT systems.

We are now looking forward to welcoming you at our booth at the Annual Meeting of SMISS November 1 to 3, 2013 and DWG, the German Spine Society, December 5 to 7, 2013. See you in Las Vegas and Frankfurt!

EUROSPINE 2013, Liverpool

NASS 2013, New Orleans

MellingMedical Adds the joimax® Suite of Full-Endoscopic, Minimally Invasive Spinal Surgery Products to Its Federal Health Portfolio

Veröffentlicht am von Antonio Berlen

MellingMedical welcomes joimax® to its federal health Portfolio

Products to improve medical care for America’s veterans, active duty and DoD

MellingMedical today announced a new agreement with an industry leader in full-endoscopic and minimally invasive spinal surgery products, welcoming joimax® to its growing portfolio of cutting edge medical-surgical offerings. The Alexandria-based company will leverage its status as an SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB) and extensive experience in federal contracting to offer joimax® products to those engaged in caring for America’s military personnel, DoD and veterans.

“We are delighted to pair up with the joimax® team to bring their innovative solutions to the realm of care for veterans, active duty military and DoD,” said Chris Melling, founder and CEO of MellingMedical. “With their sterling reputation and two dozen years of recurring innovation to their credit, they are a company with much to offer in terms of quality care.”

We are very proud of the work that has gone into our product suite and the impact we’ve had on advancing ultra-minimally-invasive procedural solutions for spinal disease,” stated joimax® Founder and CEO Wolfgang Ries. “Considering the lingering effects of spinal trauma on servicemembers, we are pleased to improve the likelihood of success for a wide array of surgical interventions. Our commitment to excellence remains unwavering as we continue to push the boundaries of what’s possible in those ultra-minimally invasive procedures.

Mr. Wolfgang Ries
CEO and Founder of joimax® 

joimax® is well known for its culture of customer attentiveness, driving innovation in response to patient needs and bringing to market products that are truly transformational. They are particularly known for their advances in spinal endoscopy, featuring products like Endoscopic Surgical Systems TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression procedures, MultiZYTE® for facet and sacroiliac joint pain treatment, EndoLIF® and Percusys® for minimally invasive endoscopically assisted stabilizations.

About MellingMedical
MellingMedical, an SBA-Verified Service-Disabled Veteran-Owned Small Business (SDVOSB), holds a Medical Equipment and Surgical Federal Supply Schedule (Med/Surg), as well as a Pharmaceutical Schedule and ECAT capabilities, providing innovative and cost-effective healthcare solutions to all 172 VA Medical Centers and 1,138 VA Outpatient Clinics, all seven (7) VA CMOPs, 95 DoD Medical Facilities and Health and Human Services (HHS), including Indian Health Services (IHS) and the Center for Disease Control (CDC). To learn more, visit MellingMedical.com.

Veröffentlicht in Allgemein